WES analysis has shown that neither of these patients had pathogenic, likely pathogenic, or variants of uncertain significance (VUS) above 50% posterior probability in genes associated with hyperphenylalaninemia (GCH1, PCBD1, PTS, QDPR, SPR and DNAJC12). This evidence concerns the gene SPR and Hyperphenylalaninemia.